Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/2QK stock hub

FRA/2QK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/2QKis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.9B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/2QK
In the news

Latest news · FRA/2QK

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-138.9
P25 n/aP50 n/aP75 n/a
ROIC-60.2
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/2QK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
128
Groups with data
11
Currency
USD
Showing 128 of 128 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

17
MetricValue
Country
United States
Country code
DE
Employees
289
Employees Change
-22%
Employees Change Percent
-14.67
Enterprise value
EUR 4.7B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 4.9B
Price
EUR 39.31
Price currency
EUR
Sic
2836
Symbol
fra/2QK
Website
https://www.scholarrock.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-7.23%
EV Earnings
-13.16x
P/B ratio
20.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Gross Profit
EUR -180.8M
Net Income
EUR -354.5M
Profit Per Employee
EUR -1.2M
ROA
-54.3
Roa5y
-35.04
ROCE
-86.11
ROE
-138.9
Roe5y
-79.49
ROIC
-60.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

3
MetricValue
Cagr1y
53.6%
Cagr3y
79.89%
Cagr5y
10.19%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Assets
EUR 464.2M
Cash
EUR 416.3M
Current Assets
EUR 436.9M
Current Liabilities
EUR 50.6M
Debt
EUR 173.1M
Debt Equity
EUR 0.72
Equity
EUR 239.4M
Interest Coverage
-59.42
Liabilities
EUR 224.8M
Long Term Assets
EUR 27.3M
Long Term Liabilities
EUR 174.3M
Net Cash
EUR 243.1M
Net Cash By Market Cap
EUR 4.96
Net Cash Growth
-6.93%
Net Debt Equity
EUR -1.02
Tangible Book Value
EUR 239.4M
Tangible Book Value Per Share
EUR 1.88

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
8.64
Net Working Capital
EUR -21.1M
Quick ratio
8.05
Working Capital
EUR 395.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-34.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
53.56%
200-day SMA
34.08
3Y total return
482.37%
50-day SMA
39.15
50-day SMA vs 200-day SMA
50over200
5Y total return
62.44%
All Time High
56.5
All Time High Change
-30.42%
All Time High Date
2021-03-16
All Time Low
4.02
All Time Low Change
877.86%
All Time Low Date
2022-06-02
ATR
0.71
Ch YTD
3.45
High
39.31
High52
44.2
High52 Date
2026-04-01
High52ch
-11.06%
Low
39.31
Low52
23
Low52 Date
2025-09-23
Low52ch
70.91%
Ma50ch
0.41%
Price vs 200-day SMA
15.34%
RSI
46.54
RSI Monthly
61.95
RSI Weekly
54.49
Sharpe ratio
0.82x
Sortino ratio
1.4
Total Return
-34.16%
Tr YTD
3.45
Tr1m
-6.47%
Tr1w
0.1%
Tr3m
5.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
EUR -355.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
100,396,461%
Shares Insiders
0.99%
Shares Institutions
92.84%
Shares Qo Q
17.35%
Shares Yo Y
34.16%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

34
MetricValue
Average Volume
13.05x
Bv Per Share
1.88
Ch1m
-6.47
Ch1w
0.1
Ch1y
53.56
Ch3m
5.67
Ch3y
482.4
Ch5y
62.44
Ch6m
59.8
Change
-1.36%
Change From Open
0
Close
39.85
Days Gap
-1.36
Depreciation Amortization
1,424,152.2
Earnings Date
2026-05-07
EBIT
EUR -355.2M
EBITDA
EUR -353.8M
EPS
EUR -2.79
F Score
0
Fiscal Year End
December
Founded
2,012
Is Primary Listing
0
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Ma150
35.77
Ma150ch
9.89%
Ma20
40.53
Ma20ch
-3.01%
Open
39.31
Price Date
2026-05-08
Ptbv Ratio
20.49
Relative Volume
12.08x
Tr6m
59.8%
Volume
0
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/2QK pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/2QK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+53.6%
S&P 500 1Y: n/a
3Y total return
+482.4%
S&P 500 3Y: n/a
5Y total return
+62.4%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/2QK?

Insider, institutional, and short-interest positioning.

Institutional ownership
+92.8%
Share of float held by funds and institutions
Insider ownership
+1.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+34.2%
Negative means the company is buying back shares.
Technical

FRA/2QK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
46.5
Neutral momentum band
Price vs 200-day MA
+15.3%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.82
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/2QK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/2QK stock rating?

fra/2QK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/2QK analysis?

The full report lives at /stocks/fra/2QK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/2QK?

The latest report frames fra/2QK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/2QK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/2QK stock profile: metrics, valuation and analysis | 股票市场 AI 助手